Author

C. F. Bartels

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1

Frequent Co-Authors

E. S. Hong· 2 shared I. Bayles· 2 shared K. Lovrenert· 2 shared P. C. Scacheri· 2 shared W. D. Pontius· 2 shared A. Lauko· 1 shared A. Lo· 1 shared A. M. Mohammadi· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. S. Hong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis

W. D. Pontius, E. S. Hong, Z. J. Faber, J. Gray, C. Peacock, I. Bayles, K. Lovrenert, C. F. Bartels, P. C. Scacheri

This study identifies dynamic chromatin accessibility changes during osteosarcoma metastasis to the lung, revealing epigenetic states critical for metastatic colonization and new therapeutic targets.

Nature Communications · Nov 8, 2023Peer-reviewedCancer Biology

Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

D. Bayik, C. F. Bartels, K. Lovrenert, D. Watson, D. Zhang, K. Kay, A. Lauko, S. Johnson, A. Lo, M. McGraw, M. Grabowski, A. M. Mohammadi, F. Veglia, Y. Fan, M. A. Vogelbaum, , J. Lathia

The paper identifies distinct cell adhesion signatures in glioblastoma myeloid-derived suppressor cell subsets, showing that monocytic MDSCs drive tumor growth through enhanced integrin β1 expression.

bioRxiv · Sep 27, 2021Immunology

Mismatch-repair signature mutations activate gene enhancers across colorectal cancer epigenomes

S. Hung, A. Saiakhova, Z. Faber, C. F. Bartels, D. Neu, I. Bayles, E. Ojo, E. S. Hong, W. D. Pontius, A. R. Morton, R. Liu, M. F. Kalady, D. N. Wald, S. Markowitz, P. C. Scacheri

The paper identifies MMR signature mutations in colorectal cancer that activate enhancers by increasing FOX factor affinity and promoting tumor growth.

bioRxiv · Sep 7, 2018Cancer Biology